ECSP045012A - 17alfa-hidroxi-14beta-esteroides con efecto hormonal - Google Patents

17alfa-hidroxi-14beta-esteroides con efecto hormonal

Info

Publication number
ECSP045012A
ECSP045012A EC2004005012A ECSP045012A ECSP045012A EC SP045012 A ECSP045012 A EC SP045012A EC 2004005012 A EC2004005012 A EC 2004005012A EC SP045012 A ECSP045012 A EC SP045012A EC SP045012 A ECSP045012 A EC SP045012A
Authority
EC
Ecuador
Prior art keywords
17alfa
14beta
hydroxi
steroids
hormonal effect
Prior art date
Application number
EC2004005012A
Other languages
English (en)
Spanish (es)
Inventor
Der Louw Jaap Van
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8180920&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP045012(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ECSP045012A publication Critical patent/ECSP045012A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0062—Estrane derivatives substituted in position 17 alfa not substituted in position 17 beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EC2004005012A 2001-09-12 2004-03-10 17alfa-hidroxi-14beta-esteroides con efecto hormonal ECSP045012A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01203455 2001-09-12

Publications (1)

Publication Number Publication Date
ECSP045012A true ECSP045012A (es) 2004-09-27

Family

ID=8180920

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2004005012A ECSP045012A (es) 2001-09-12 2004-03-10 17alfa-hidroxi-14beta-esteroides con efecto hormonal

Country Status (28)

Country Link
US (1) US7169769B2 (enExample)
EP (1) EP1427748B1 (enExample)
JP (1) JP4471653B2 (enExample)
KR (1) KR100940054B1 (enExample)
CN (1) CN1257913C (enExample)
AR (1) AR036462A1 (enExample)
AT (1) ATE395352T1 (enExample)
AU (1) AU2002339536B2 (enExample)
BR (1) BR0212409A (enExample)
CA (1) CA2505575C (enExample)
CY (1) CY1108152T1 (enExample)
DE (1) DE60226623D1 (enExample)
DK (1) DK1427748T3 (enExample)
EC (1) ECSP045012A (enExample)
ES (1) ES2305306T3 (enExample)
HR (1) HRP20040193A2 (enExample)
HU (1) HUP0402139A3 (enExample)
IL (2) IL160451A0 (enExample)
IS (1) IS2555B (enExample)
MX (1) MXPA04002418A (enExample)
NO (1) NO326624B1 (enExample)
NZ (1) NZ531487A (enExample)
PL (1) PL207493B1 (enExample)
PT (1) PT1427748E (enExample)
RU (1) RU2294332C2 (enExample)
TW (1) TWI221154B (enExample)
WO (1) WO2003022864A1 (enExample)
ZA (1) ZA200401992B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI221154B (en) 2001-09-12 2004-09-21 Akzo Nobel Nv 17alpha-hydroxy-14beta-steroids with hormonal effect

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3338925A (en) * 1965-10-25 1967-08-29 Syntex Corp 17-substituted 14beta-estr-4-enes
WO2000053619A1 (en) * 1999-03-08 2000-09-14 Akzo Nobel N.V. 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens
AU4299301A (en) * 2000-02-29 2001-09-12 National University Of Singapore, The A method for modulating steroidogenic activity
US6391868B2 (en) * 2000-05-10 2002-05-21 Lpt Research, Inc. Use of 5-alpha-androst-1-en-3,17-dione to increase the level of the anabolic/androgenic hormone 17-beta-hydroxy-5-alpha-androst-1-en-3-one in humans
TWI221154B (en) 2001-09-12 2004-09-21 Akzo Nobel Nv 17alpha-hydroxy-14beta-steroids with hormonal effect

Also Published As

Publication number Publication date
RU2294332C2 (ru) 2007-02-27
WO2003022864A1 (en) 2003-03-20
ATE395352T1 (de) 2008-05-15
PL207493B1 (pl) 2010-12-31
CA2505575C (en) 2010-01-26
US20040259849A1 (en) 2004-12-23
AR036462A1 (es) 2004-09-08
NO326624B1 (no) 2009-01-19
AU2002339536B2 (en) 2008-04-24
CA2505575A1 (en) 2003-03-20
HUP0402139A2 (hu) 2005-02-28
CN1553917A (zh) 2004-12-08
IS7165A (is) 2004-02-26
HK1063637A1 (en) 2005-01-07
JP4471653B2 (ja) 2010-06-02
IS2555B (is) 2009-10-15
RU2004110934A (ru) 2005-08-20
PL368727A1 (en) 2005-04-04
CN1257913C (zh) 2006-05-31
JP2005505566A (ja) 2005-02-24
MXPA04002418A (es) 2004-07-30
ZA200401992B (en) 2005-04-21
NZ531487A (en) 2005-08-26
NO20041010L (no) 2004-03-10
EP1427748B1 (en) 2008-05-14
BR0212409A (pt) 2004-08-03
IL160451A0 (en) 2004-07-25
KR100940054B1 (ko) 2010-02-04
DK1427748T3 (da) 2008-09-08
KR20040039346A (ko) 2004-05-10
ES2305306T3 (es) 2008-11-01
EP1427748A1 (en) 2004-06-16
HUP0402139A3 (en) 2012-12-28
HRP20040193A2 (en) 2004-08-31
DE60226623D1 (de) 2008-06-26
PT1427748E (pt) 2008-08-27
IL160451A (en) 2009-11-18
US7169769B2 (en) 2007-01-30
CY1108152T1 (el) 2014-02-12
TWI221154B (en) 2004-09-21

Similar Documents

Publication Publication Date Title
AR109354A2 (es) Una composición que comprende un compuesto bicíclico y compuesto
BR0211540A (pt) Instalação de energia eólica, dispositivo para a produção de um estator de uma máquina sìncrona, máquina sìncrona, uso da mesma, e, gerador anular para uma instalação de energia eólica
PE20020179A1 (es) DERIVADOS DE (6S,9R,10S,11S,13S,16R, 17R)-9-CLORO-6-FLUORO-11-HIDROXI-10,13,16-TRIMETIL-3-OXO-6,7,8,9,10,11,12,13,14,15,16,17-DODECAHIDRO-3H-CICLOPENTA[a]FENANTRENO CARBOXILICO
AR006680A1 (es) Composicion surfactante que comprende sulfatos de alquilo ramificados y dichos compuestos
PT1427280E (pt) Novos compostos
BR0111780A (pt) Agente herbicida
CL2004000026A1 (es) Uso de una composicion que comprende 0 a alrededor de 29% de cis-clomifeno y de alrededor de 100 a alrededor de 71% de trans-clomifeno para preparar un medicamento util para aumentar los niveles de testosterona en suero en un mamifero masculino.
MX2011008942A (es) Derivados de benzotiazinas, su preparacion y aplicacion como farmacos.
ECSP045012A (es) 17alfa-hidroxi-14beta-esteroides con efecto hormonal
ES2107806T3 (es) Nuevos esteroides.
NO20022977L (no) Substituerte homopiperidinylbenzimidazolanaloger som fundiske relaksanter
AR045668A1 (es) Mezcla de agentes tensioactivos y solventes
ES2175963T3 (es) Compuesto de tia-eter corona.
ATE426792T1 (de) Nicht reizende gel-zusammensetzungen
BR0009214A (pt) Composições aquosas estáveis contendo umcomposto de silìcio
BR0315647A (pt) Novos compostos para composições de tingimento de cabelos
PE20020752A1 (es) Esteroides con doble enlace delta 14 sustituido en las posiciones 13 y 14 con actividad androgenica y progestagena
ECSP067028A (es) Profármacos de esteroides con acción androgénica
BR0001628A (pt) Processo para a preparação de um composto aromático substituìdo por uma nitrila terciária
TH83886B (th) 17แอลฟา-ไฮดรอกซิ-14บีตา-สเทียรอยด์ที่มีผลของฮอร์โมน
ES2195500T3 (es) Dereivados del 2-indanometanol y su utilizacion a titulo de ingredientes perfumantes.
DK1417265T3 (da) Flydende farvesammensætninger med acyglyceroler som dispergeringsmidler
ZA818673B (en) Derivatives of steroids 3-keto delta 4 or delta 1,4 substituted in position 7,their preparation,their application as medicaments and the compositions containing them
TW200707097A (en) Coloring agent dispersion and photosensitive combination using the same
AR030466A1 (es) Una composicion para el tratamiento del cabello